Claims for Patent: 8,460,860

Summary for Patent: 8,460,860

Title:	Cancellous bone treated with collagenase and essentially free of blood cells
Abstract:	A bone implant comprising cancellous bone that is essentially free of blood cells, and which has been treated with at least a loosening agent, such as collagenase and/or a digestive enzyme, for a time and at a concentration to loosen the osteogenic cells in the cancellous bone matrix. The osteogenic cells in the matrix are viable cells. The treatment of the cancellous bone with at least one loosening agent enables the osteogenic cells to be more available for carrying our their osteogenic function and to provide for an increased rate of bone formation.
Inventor(s):	Williams; Michelle LeRoux (Laurel, MD), Mills; Charles Randal (Finksburg, MD), Monroy; Rodney (Aberdeen, MD)
Assignee:	NuVasive, Inc. (San Diego, CA)
Application Number:	11/799,606
Patent Claims:	1. A bone product, comprising: cancellous bone, said cancellous bone being essentially free of blood cells and having been treated with at least one loosening agent for about 5 minutes to about 30 minutes and at a concentration to loosen osteogenic cells in the cancellous bone matrix, said osteogenic cells in the cancellous bone matrix being viable cells, and a cryopreservation solution, wherein said cancellous bone and said cryopreservation solution are combined and stored in a sealed jar. 2. The bone product of claim 1 wherein said at least one loosening agent is selected from the group consisting of collagenase and digestive enzymes. 3. The bone product of claim 2 wherein said at least one loosening agent is collagenase. 4. The bone product of claim 3 wherein said bone is treated with said collagenase at a concentration of from about 0.1 mg/ml to about 3.0 mg/ml. 5. The bone product of claim 4 wherein said bone is treated with said collagenase at a concentration of from about 1.0 mg/ml to about 3.0 mg/ml. 6. The bone product of claim 3 wherein said bone is treated with said collagenase at a concentration of about 1.0 mg/ml for a period of time from about 10 minutes. 7. The bone product of claim 1, wherein said cancellous bone is further treated with an antibiotic and/or antimycotic. 8. The bone product of claim 1, wherein the cryopreservation solution comprises dimethylsulfoxide.

Details for Patent 8,460,860

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Smith & Nephew, Inc.	SANTYL	collagenase	Ointment	101995	06/04/1965		2026-05-08